ATE235916T1 - Verfahren zur herstellung von gegen e.coli bakterien der familie cs4-cfa/1 gerichteten antikörpern - Google Patents

Verfahren zur herstellung von gegen e.coli bakterien der familie cs4-cfa/1 gerichteten antikörpern

Info

Publication number
ATE235916T1
ATE235916T1 AT96918041T AT96918041T ATE235916T1 AT E235916 T1 ATE235916 T1 AT E235916T1 AT 96918041 T AT96918041 T AT 96918041T AT 96918041 T AT96918041 T AT 96918041T AT E235916 T1 ATE235916 T1 AT E235916T1
Authority
AT
Austria
Prior art keywords
cfa
family
consensus
peptide
directed against
Prior art date
Application number
AT96918041T
Other languages
English (en)
Inventor
Frederick Cassels
Jeffrey Anderson
John Mark Carter
Original Assignee
Dept Of The Army Us Government
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dept Of The Army Us Government filed Critical Dept Of The Army Us Government
Application granted granted Critical
Publication of ATE235916T1 publication Critical patent/ATE235916T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1228—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K16/1232—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia from Escherichia (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT96918041T 1995-06-02 1996-06-03 Verfahren zur herstellung von gegen e.coli bakterien der familie cs4-cfa/1 gerichteten antikörpern ATE235916T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/460,617 US5914114A (en) 1995-06-02 1995-06-02 Method of raising antibodies against E. coli of the family CS4-CFA/I
PCT/US1996/008730 WO1996038171A1 (en) 1995-06-02 1996-06-03 Methods of raising antibodies against e.coli of the family cs4-cfa/1

Publications (1)

Publication Number Publication Date
ATE235916T1 true ATE235916T1 (de) 2003-04-15

Family

ID=23829417

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96918041T ATE235916T1 (de) 1995-06-02 1996-06-03 Verfahren zur herstellung von gegen e.coli bakterien der familie cs4-cfa/1 gerichteten antikörpern

Country Status (8)

Country Link
US (1) US5914114A (de)
EP (1) EP0831900B1 (de)
AT (1) ATE235916T1 (de)
CA (1) CA2223013C (de)
DE (1) DE69627150T2 (de)
DK (1) DK0831900T3 (de)
ES (1) ES2196155T3 (de)
WO (1) WO1996038171A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2252438C (en) * 1996-04-19 2011-03-29 Henry M. Jackson Foundation For The Advancement Of Military Medicine Histidine-tagged intimin and methods of using intimin to stimulate an immune response and as an antigen carrier with targeting capability
US7404961B2 (en) * 1996-08-02 2008-07-29 The United States Of America As Represented By The Secretary Of The Army Peptides responsive to antibodies against consensus peptide of the CS4-CFA/I family proteins
ES2230617T3 (es) * 1996-08-02 2005-05-01 DEPARTMENT OF THE ARMY, U.S. GOVERNMENT U.S. ARMY MEDICAL RES. & MATERIEL COMMAND, ELIZABETH ARWINE Peptidos sensibles a anticuerpos contra un peptido consenso de las proteinas de la familia cs4-cfa/i.
US7094883B1 (en) * 1996-08-02 2006-08-22 The United States Of America As Represented By The Secretary Of The Army Monoclonal antibody which agglutinates E. coli having the CS4-CFA/I family protein
JP2000516805A (ja) * 1996-08-02 2000-12-19 デパートメント オブ ザ アーミー，ユー．エス．ガバメント ＣＳ４―ＣＦＡ／Ｉファミリータンパク質を有するＥ．ｃｏｌｉを凝集させるモノクローナル抗体
US20060002959A1 (en) * 1996-11-14 2006-01-05 Government Of The United States Skin-sctive adjuvants for transcutaneous immuization
US20060002949A1 (en) 1996-11-14 2006-01-05 Army Govt. Of The Usa, As Rep. By Secretary Of The Office Of The Command Judge Advocate, Hq Usamrmc. Transcutaneous immunization without heterologous adjuvant
US6797276B1 (en) * 1996-11-14 2004-09-28 The United States Of America As Represented By The Secretary Of The Army Use of penetration enhancers and barrier disruption agents to enhance the transcutaneous immune response
US5980898A (en) * 1996-11-14 1999-11-09 The United States Of America As Represented By The U.S. Army Medical Research & Material Command Adjuvant for transcutaneous immunization
US7422747B2 (en) * 1997-10-07 2008-09-09 Loma Linda University Transgenic plant-based vaccines
US20040258703A1 (en) * 1997-11-14 2004-12-23 The Government Of The Us, As Represented By The Secretary Of The Army Skin-active adjuvants for transcutaneous immunization
AU4188100A (en) * 1999-04-08 2000-11-14 Gregory M. Glenn Dry formulation for transcutaneous immunization
WO2001005827A1 (en) * 1999-07-15 2001-01-25 Medimmune, Inc. Fima PILUS-BASED VACCINES
AU7304000A (en) * 1999-09-22 2001-04-24 Isis Innovation Limited Virulence gene and protein, and their use
MXPA02010407A (es) * 2000-04-20 2003-05-23 Univ Maryland Aislamiento y caracterizacion del operante csa (etec-cs4-pili) y metodos para su uso.
IES20010042A2 (en) * 2001-01-19 2002-12-11 Enfer Technology Ltd Test for transmissible spongiform encephalopathies
JP2005504002A (ja) * 2001-02-13 2005-02-10 ガバメント オブ ザ ユナイテッド ステイツ、 アズ リプリゼンティッド バイ ザ セクレタリィ オブ ジ アーミイ 経皮免疫感作のためのワクチン
WO2003076643A2 (en) * 2002-02-25 2003-09-18 U.S. Army Medical Research And Materiel Command Method of making cs6 antigen vaccine for treating, preventing, or inhibiting enterotoxigenic escherichia coli infections
US20060269560A1 (en) * 2005-05-24 2006-11-30 Savarino Stephen J Anti-adhesin based passive immunoprophlactic

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4411888A (en) * 1981-06-22 1983-10-25 The University Of Rochester Composition of a novel immunogen for protection against diarrheal disease caused by enterotoxigenic Escherichia coli
US4443549A (en) * 1981-10-19 1984-04-17 Molecular Genetics, Inc. Production of monoclonal antibodies against bacterial adhesins
US4971794A (en) * 1982-09-02 1990-11-20 Unilever Patent Holdings B.V. Production of antibodies using a mixture of strains of E. coli collectively expressing type I pili, CFA I pili, CFA II pili and K88 pili
US5417986A (en) * 1984-03-16 1995-05-23 The United States Of America As Represented By The Secretary Of The Army Vaccines against diseases caused by enteropathogenic organisms using antigens encapsulated within biodegradable-biocompatible microspheres
US5017372A (en) * 1986-04-14 1991-05-21 Medicis Corporation Method of producing antibody-fortified dry whey
DE3871489D1 (de) * 1987-10-26 1992-07-02 Akzo Nv Impfstoff gegen e.coli-blutvergiftung bei gefluegel.
US5071977A (en) * 1989-05-10 1991-12-10 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Plaque inhibiting oligosaccharide
US5190746A (en) * 1989-05-10 1993-03-02 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Plaque inhibiting oligosaccharide
AU8417191A (en) * 1990-07-24 1992-02-18 Emory University Production of and compositions for the major cs1 pilin antigen including vaccines and diagnostic probes
US5698416A (en) * 1995-06-02 1997-12-16 The United States Of America As Represented By The Secretary Of The Army Methods for production of antigens under control of temperature-regulated promotors in enteric bacteria
US5627163A (en) * 1995-06-05 1997-05-06 Synsorb Biotech, Inc. Treatment of traveller's diarrhea
US5637576A (en) * 1995-06-05 1997-06-10 Synsorb Biotech, Inc. Treatment of traveller's diarrhea

Also Published As

Publication number Publication date
EP0831900A1 (de) 1998-04-01
EP0831900A4 (de) 1999-01-20
ES2196155T3 (es) 2003-12-16
CA2223013A1 (en) 1996-12-05
DE69627150T2 (de) 2004-01-29
CA2223013C (en) 2011-03-22
DE69627150D1 (de) 2003-05-08
EP0831900B1 (de) 2003-04-02
DK0831900T3 (da) 2003-07-21
US5914114A (en) 1999-06-22
WO1996038171A1 (en) 1996-12-05

Similar Documents

Publication Publication Date Title
ATE235916T1 (de) Verfahren zur herstellung von gegen e.coli bakterien der familie cs4-cfa/1 gerichteten antikörpern
DE69333802T8 (de) Äusseres membranprotein von haemophilus
ATE421587T1 (de) Neue escherichia coli-stämme, methoden zu deren herstellung und benutzung dieser in fermentationsprozessen zur produktion von l- threonin
ATE170630T1 (de) Proteine mit geänderten epitopen und verfahren zur deren herstellung
KR890006668A (ko) 폴리펩티드
EA199700248A1 (ru) Выделенный по существу очищенный поверхностный антиген белковой природы neisseria и фрагмент этого антигена
DE69840195D1 (de) Verfahren und zusammensetzungen zur behinderung der vervielfältigung von hiv-1
DE69636720D1 (de) Dem fibroblasten wachstumsfaktor homologer faktor-1(fhf-1) und methoden zu seiner verwendung
ATE174928T1 (de) Peptidzusammensetzung von exoenzym s von pseudomonas und verfahren zu deren erstellung
DE69018926T2 (de) Vakzine gegen Bordetella.
ATE184612T1 (de) Peptidzusammensetzung aus pseudomonas und methode diese herzustellen
ATE227307T1 (de) Verfahren zur herstellung modifizierten proteine
ATE94880T1 (de) Synthetische peptide, gegen diese gerichtete antikoerper und deren verwendung.
DK38889A (da) Onkogen-indkodet polypeptid med vaekstfaktoraktivitet
ATE290088T1 (de) Verfahren zur spaltung eines chimeren proteins mittels eines 'processing'-enzyms
EP0312157A3 (de) Tetrapeptid-Renin-Inhibitoren mit C-terminalen Aminosäureamiden
DE60139952D1 (de) Immunogene glycopeptide. screening- und herstellungsverfahren sowie verwendungen
ATE293163T1 (de) Cyclin e spezifische konstrukte und komplexe
AU6306390A (en) Antibodies against highly conserved amino acid sequences of immunogenic substances, a process for the preparation of these antibodies and the use thereof in immunoassays
CA2262893A1 (en) Peptides responsive to antibodies against a consensus peptide of the cs4-cfa/i family proteins
ATE102950T1 (de) Verfahren zur herstellung von dipeptiden mit cterminalen nicht-proteinogenen aminosaeuren.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0831900

Country of ref document: EP

REN Ceased due to non-payment of the annual fee